Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 45401-45450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05252312
Perception of Nonverbal Acoustic Signals and Resulting Physiological Responses (SINOVE-PER)
N/ARecruiting
2,000 participants
Started: Nov 29, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05893966
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
N/ARecruiting
400 participants
Started: Nov 29, 2022 · Completed: Nov 29, 2032
1 condition1 sponsor1 location
NCT05421897
Rapid Administration Pilot for Infusing Dinutuximab
PHASE1Recruiting
11 participants
Started: Nov 29, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05420584
Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer
PHASE2Recruiting
83 participants
Started: Nov 29, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05383339
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
N/ARecruiting
2,250 participants
Started: Nov 29, 2022 · Completed: Nov 29, 2031
3 conditions2 sponsors1 location
NCT05686798
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PHASE1Recruiting
18 participants
Started: Nov 29, 2022 · Completed: Oct 31, 2026
9 conditions1 sponsor1 location
NCT05659056
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
PHASE2Recruiting
65 participants
Started: Nov 29, 2022 · Completed: Jul 31, 2024
1 condition2 sponsors1 location
NCT04761393
Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
N/ARecruiting
45 participants
Started: Nov 29, 2022 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT05584670
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
291 participants
Started: Nov 29, 2022 · Completed: Nov 7, 2028
1 condition1 sponsor21 locations
NCT05640843
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NARecruiting
150 participants
Started: Nov 29, 2022 · Completed: Nov 30, 2026
2 conditions7 sponsors8 locations
NCT04330846
Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.
NARecruiting
40 participants
Started: Nov 29, 2022 · Completed: Apr 1, 2027
1 condition1 sponsor16 locations
NCT04939935
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
PHASE3Recruiting
1,174 participants
Started: Nov 29, 2022 · Completed: May 31, 2027
1 condition1 sponsor40 locations
NCT05560113
Disrupting Fear-based Memory Consolidation
NARecruiting
66 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05577754
Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
PHASE2Recruiting
20 participants
Started: Nov 28, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors13 locations
NCT06030349
Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome
N/ARecruiting
200 participants
Started: Nov 28, 2022 · Completed: Dec 28, 2027
5 conditions6 sponsors6 locations
NCT05562505
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NARecruiting
140 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2027
6 conditions2 sponsors7 locations
NCT05588167
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
N/ARecruiting
100 participants
Started: Nov 28, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05728307
Post-market Observation of a Wireless Vital Sign Monitor for Hospitalized Newborns in Kenya
N/ARecruiting
3,000 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2023
2 conditions3 sponsors1 location
NCT05546658
Effects of Psilocybin in Obsessive Compulsive Disorder
EARLY_PHASE1Recruiting
30 participants
Started: Nov 28, 2022 · Completed: Sep 12, 2027
1 condition2 sponsors1 location
NCT05428488
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
PHASE3Recruiting
220 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor17 locations
NCT05754658
African Cancer Genome: GMD
N/ARecruiting
1,500 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2025
2 conditions14 sponsors1 location
NCT05503225
Colchicine Use in Intracranial Atherosclerotic Disease
PHASE2Recruiting
72 participants
Started: Nov 28, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06217848
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
EARLY_PHASE1Recruiting
50 participants
Started: Nov 28, 2022 · Completed: Mar 8, 2024
3 conditions1 sponsor1 location
NCT05457010
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
PHASE1Recruiting
24 participants
Started: Nov 28, 2022 · Completed: Nov 17, 2025
2 conditions1 sponsor5 locations
NCT06355323
Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
NARecruiting
75 participants
Started: Nov 28, 2022 · Completed: Nov 28, 2025
4 conditions1 sponsor1 location
NCT06533137
"How Awareness and Subjectivity Modulate the Placebo Effect"
NARecruiting
84 participants
Started: Nov 28, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06143969
Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism
N/ARecruiting
180 participants
Started: Nov 28, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05445856
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy
PHASE4Recruiting
130 participants
Started: Nov 28, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05768048
Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments
N/ARecruiting
500 participants
Started: Nov 28, 2022 · Completed: Nov 27, 2027
1 condition5 sponsors5 locations
NCT05865197
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF
N/ARecruiting
20 participants
Started: Nov 28, 2022 · Completed: Sep 1, 2024
2 conditions1 sponsor1 location
NCT05470205
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
PHASE3Recruiting
660 participants
Started: Nov 28, 2022 · Completed: Apr 30, 2026
2 conditions4 sponsors3 locations
NCT06514235
Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)
N/ARecruiting
300 participants
Started: Nov 28, 2022 · Completed: Nov 30, 2033
1 condition7 sponsors1 location
NCT05179226
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
PHASE3Recruiting
200 participants
Started: Nov 28, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05729061
Analysis of Human Movement With Assistive Devices
NARecruiting
100 participants
Started: Nov 28, 2022 · Completed: Nov 28, 2024
4 conditions2 sponsors1 location
NCT05809414
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis
PHASE3Recruiting
144 participants
Started: Nov 28, 2022 · Completed: Feb 28, 2025
2 conditions1 sponsor4 locations
NCT05149625
Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy
NARecruiting
172 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06590883
The STatus Epilepticus Prognosis Study
N/ARecruiting
50 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05340465
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
PHASE2Recruiting
120 participants
Started: Nov 27, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT06005870
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
PHASE2Recruiting
41 participants
Started: Nov 26, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07139860
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
N/ARecruiting
1,400 participants
Started: Nov 26, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04279158
Attention Modulation of Local and Global Inhibition Mechanisms
NARecruiting
120 participants
Started: Nov 26, 2022 · Completed: Nov 26, 2028
1 condition1 sponsor1 location
NCT05762029
Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning
N/ARecruiting
60 participants
Started: Nov 26, 2022 · Completed: Nov 26, 2025
2 conditions1 sponsor1 location
NCT05644392
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
PHASE1Recruiting
30 participants
Started: Nov 25, 2022 · Completed: Nov 25, 2025
1 condition1 sponsor1 location
NCT06785506
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
N/ARecruiting
200 participants
Started: Nov 25, 2022 · Completed: Sep 1, 2026
3 conditions6 sponsors6 locations
NCT05469984
Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor
NARecruiting
600 participants
Started: Nov 25, 2022 · Completed: Sep 26, 2025
2 conditions1 sponsor1 location
NCT05522881
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
N/ARecruiting
410 participants
Started: Nov 25, 2022 · Completed: Dec 30, 2029
1 condition7 sponsors7 locations
NCT05428826
Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
PHASE4Recruiting
41 participants
Started: Nov 25, 2022 · Completed: Nov 25, 2028
1 condition1 sponsor15 locations
NCT06430047
Efficacy and Safety of EsoDuo®
PHASE4Recruiting
180 participants
Started: Nov 25, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05644379
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
PHASE1Recruiting
30 participants
Started: Nov 25, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05524168
SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma
PHASE2Recruiting
41 participants
Started: Nov 25, 2022 · Completed: Dec 31, 2026
1 condition6 sponsors1 location